PharmaLundensis AB (XSAT:PHAL BTA) Total Liabilities : kr6.46 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is PharmaLundensis AB Total Liabilities?

PharmaLundensis AB's Total Liabilities for the quarter that ended in Mar. 2025 was kr6.46 Mil.

PharmaLundensis AB's quarterly Total Liabilities declined from Sep. 2024 (kr7.26 Mil) to Dec. 2024 (kr6.19 Mil) but then increased from Dec. 2024 (kr6.19 Mil) to Mar. 2025 (kr6.46 Mil).

PharmaLundensis AB's annual Total Liabilities increased from Dec. 2022 (kr7.00 Mil) to Dec. 2023 (kr7.45 Mil) but then declined from Dec. 2023 (kr7.45 Mil) to Dec. 2024 (kr6.19 Mil).

PharmaLundensis AB Total Liabilities Historical Data

The historical data trend for PharmaLundensis AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Total Liabilities Chart

PharmaLundensis AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

4.72

5.11

7.00

7.45

6.19

PharmaLundensis AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															7.90	7.28	7.26	6.19	6.46

PharmaLundensis AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PharmaLundensis AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.522	+	(1.667	+	0.0010000000000001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	6.19

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	10.072	-	3.882
	=	6.19

PharmaLundensis AB's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	4.773	+	(1.689	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	6.46

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	11.667	-	5.205
	=	6.46

PharmaLundensis AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

PHAL:Sweden

Address

PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines